Digital Application-Based Nursing Intervention
ConditionKidney Transplantation
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age20-65
SponsorAssiut University
About this trial
The purpose of this study is to evaluate the effect of a digital application-based nursing intervention on improving health outcomes among kidney transplant recipients. Following kidney transplantation, patients face critical, lifelong challenges that require strict adherence to immunosuppressive therapy and rigorous self-management behaviors to prevent graft rejection and mortality. This study introduces a dual-component nursing intervention comprising an illustrated educational booklet and the implementation of the "MyTherapy" mobile health application. The study aims to determine whether combining tailored patient education with real-time digital medication reminders and symptom tracking can successfully enhance medication adherence, improve daily self-management behaviors, and reduce the self-perceived burden among transplant recipients during their post-operative recovery phase.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adult kidney transplant recipients (aged 20-65 years).
Patients transplanted between June 2024 and June 2026 who are currently maintained on regular outpatient follow-up.
Patients who have access to a smartphone compatible with the mobile application.
Disqualifiers
Patients and family members who are illiterate or unable to use the mobile application effectively due to literacy limitations.
Patients with severe cognitive impairment or psychiatric conditions
Patients with auditory and visual disorders.
Patients with failed graft.
Trial design
Design model
Single group
Treatments tested in this trial
Digital Application-Based Nursing Intervention
BehavioralA multi-component, digital application-based nursing intervention designed to improve post-transplant health outcomes. The intervention consists of two main components: 1) The MyTherapy smartphone application, utilized by patients to receive tailored medication reminders, track post-operative symptoms, and maintain daily health logs. 2) A comprehensive, illustrated educational booklet written in simple Arabic to guide patients on essential post-transplant self-care, medication compliance, vital signs self-monitoring, and necessary lifestyle modifications.
Treatment groups
50 Participants
are divided into 1 treatment groupGroup A: Experimental groupExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Change in Medication Adherence
Medication adherence will be assessed using the 8-item Morisky Medication Adherence Scale (MMAS-8). Total scores range from 0 to 8, where higher scores indicate better adherence levels (high adherence = 8, medium adherence = 6 to \<8, low adherence = \<6).
Time frame
Baseline, 1 month, and 3 months post-interventionSecondary outcomes
1
Change in Patient Self-Management Behaviors
Self-management will be evaluated using the Self-Management Scale for Kidney Transplant Recipients (KTR-SMS). Total scores range from 24 to 96, with higher scores reflecting greater patient self-management capabilities (high = 71-96, moderate = 55-70, low = 24-54).
Time frame
Baseline, 1 month, and 3 months post-intervention2
Change in Self-Perceived Burden
The extent to which patients feel their care places a strain on caregivers will be measured using the Self-Perceived Burden Scale. Total scores range from 10 to 50, with higher scores indicating a greater self-perceived burden (high burden = 21-50, low burden = 10-20).
Time frame
Baseline, 1 month, and 3 months post-interventionSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: